Article Information
History
- February 8, 2021.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Hitoshi Kawasuji1,
- Yoshitomo Morinaga2,
- Hideki Tani3,
- Miyuki Kimura2,
- Hiroshi Yamada2,
- Yoshihiro Yoshida2,
- Yusuke Takegoshi1,
- Makito Kaneda1,
- Yushi Murai1,
- Kou Kimoto1,
- Akitoshi Ueno1,
- Yuki Miyajima1,
- Koyomi Kawago1,
- Yasutaka Fukui1,
- Ippei Sakamaki1 and
- Yoshihiro Yamamoto1,#
- 1Department of Clinical Infectious Diseases, Toyama University Graduate School of Medicine and Pharmaceutical Sciences, University of Toyama, 2630 Sugitani, Toyama, 930-0194, Japan
- 2Department of Microbiology, Toyama University Graduate School of Medicine and Pharmaceutical Sciences, University of Toyama, 2630 Sugitani, Toyama, 930-0194, Japan
- 3Department of Virology, Toyama Institute of Health, 17-1 Nakataikoyama, Imizu-shi, Toyama, 939-0363, Japan
- ↵#Correspondence:
Yoshihiro Yamamoto, MD, PhD, Department of Clinical Infectious Diseases, Graduate School of Medicine and Pharmaceutical Sciences, University of Toyama, 2630 Sugitani, Toyama, 930-0194, Japan., Tel: 076-434-7245, E-mail: yamamoto{at}med.u-toyama.ac.jp
Posted February 08, 2021.
Dynamics of neutralizing antibody responses in acute-phase COVID-19: A potential relationship between disease progression and rapid neutralizing antibody response
